Concepedia

Yongjin Xu

YX

Statistics

Publications

37

Citations

1.4K

H-Index

21

Active since

1992

Affiliations

Chinese Academy of Sciences(Current)

Sichuan University

State Key Laboratory of Biotherapy

University of Chinese Academy of Sciences

University of Gothenburg

Yongjin Xu is an author at Chinese Academy of Sciences specializing in drug discovery, pharmacy, and medicinal chemistry.

ORCID

Publications per year

1992–2024

37

Publications

37

Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase

Wei‐Sheng Huang, Shuangying Liu, Dong Zou et al. · Journal of Medicinal Chemistry · 2016 · 404 citations · Full text

, , +13

Using Molecular Equivalence Numbers To Visually Explore Structural Features that Distinguish Chemical Libraries

Yongjin Xu, Mark A. Johnson · Journal of Chemical Information and Computer Sciences · 2002 · 110 citations

, , +17

Fragment Growing and Linking Lead to Novel Nanomolar Lactate Dehydrogenase Inhibitors

Anna Kohlmann, Stephan G. Zech, Feng Li et al. · Journal of Medicinal Chemistry · 2013 · 85 citations · Full text

, , +17

Algorithm for Naming Molecular Equivalence Classes Represented by Labeled Pseudographs

Yongjin Xu, Mark A. Johnson · Journal of Chemical Information and Computer Sciences · 2001 · 80 citations

, , +14

Structural Feature Analyzation Strategies toward Discovery of Orally Bioavailable PROTACs of Bruton’s Tyrosine Kinase for the Treatment of Lymphoma

Jingyu Zhang, Jinxin Che, Xiaomin Luo et al. · Journal of Medicinal Chemistry · 2022 · 51 citations · Full text

, , +17

1–5 of 37